These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 791234)

  • 61. Treatment efficacy of intramuscular promethazine for space motion sickness.
    Davis JR; Jennings RT; Beck BG; Bagian JP
    Aviat Space Environ Med; 1993 Mar; 64(3 Pt 1):230-3. PubMed ID: 8447805
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Accidental mydriasis from scopolamine patches.
    Rosen NB
    J Am Optom Assoc; 1986 Jul; 57(7):541-2. PubMed ID: 3745760
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Transdermal scopolamine: a review of its effects upon motion sickness, psychological performance, and physiological functioning.
    Parrott AC
    Aviat Space Environ Med; 1989 Jan; 60(1):1-9. PubMed ID: 2647072
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Evaluation of antimotion sickness drugs: a new effective remedy revealed.
    Wood CD; Graybiel A
    Aerosp Med; 1970 Aug; 41(8):932-3. PubMed ID: 4988606
    [No Abstract]   [Full Text] [Related]  

  • 65. Transderm Scop patches for prevention of motion sickness.
    Johnson P; Hansen D; Matarazzo D; Petterson L; Swisher C; Trappolini A
    N Engl J Med; 1984 Aug; 311(7):468-9. PubMed ID: 6749195
    [No Abstract]   [Full Text] [Related]  

  • 66. Effects of scopolamine on autonomic profiles underlying motion sickness susceptibility.
    Uijtdehaage SH; Stern RM; Koch KL
    Aviat Space Environ Med; 1993 Jan; 64(1):1-8. PubMed ID: 8424733
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prokinetic effects of erythromycin after antimotion sickness drugs.
    Stewart JJ; Wood MJ; Parish RC; Wood CD
    J Clin Pharmacol; 2000 Apr; 40(4):347-53. PubMed ID: 10761161
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A comparison of the efficacy of cinnarizine with scopolamine in the treatment of seasickness.
    Pingree BJ; Pethybridge RJ
    Aviat Space Environ Med; 1994 Jul; 65(7):597-605. PubMed ID: 7945125
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Efficacy of histaminergic drugs in experimental motion sickness.
    Matsnev EI; Sigaleva EE
    J Vestib Res; 2007; 17(5-6):313-21. PubMed ID: 18626141
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Motion sickness and its prevention by drugs.
    Brand JJ
    Curr Med Drugs; 1967 Aug; 7(12):17-26. PubMed ID: 6064966
    [No Abstract]   [Full Text] [Related]  

  • 71. Differential effects of scopolamine and amphetamine on microcomputer-based performance tests.
    Kennedy RS; Odenheimer RC; Baltzley DR; Dunlap WP; Wood CD
    Aviat Space Environ Med; 1990 Jul; 61(7):615-21. PubMed ID: 2386447
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [The treatment of seasickness with Kinetosin].
    May W
    Dtsch Gesundheitsw; 1965 Jul; 20(27):1234-6. PubMed ID: 5319776
    [No Abstract]   [Full Text] [Related]  

  • 73. Stimulation of the semicircular canals via the rotary chair as a means to test pharmacologic countermeasures for space motion sickness.
    Dornhoffer J; Chelonis JJ; Blake D
    Otol Neurotol; 2004 Sep; 25(5):740-5. PubMed ID: 15354005
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Transdermal scopolamine intoxication in a child.
    Klein BL; Ashenburg CA; Reed MD
    Pediatr Emerg Care; 1985 Dec; 1(4):208-9. PubMed ID: 3842169
    [No Abstract]   [Full Text] [Related]  

  • 75. Controlled-release transdermal drug delivery.
    Kelly HW
    Cutis; 1985 Mar; 35(3):204, 207. PubMed ID: 3920010
    [No Abstract]   [Full Text] [Related]  

  • 76. Use of promethazine to hasten adaptation to provocative motion.
    Lackner JR; Graybiel A
    J Clin Pharmacol; 1994 Jun; 34(6):644-8. PubMed ID: 8083396
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Modafinil as a potential motion sickness countermeasure.
    Hoyt RE; Lawson BD; McGee HA; Strompolis ML; McClellan MA
    Aviat Space Environ Med; 2009 Aug; 80(8):709-15. PubMed ID: 19653573
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Patient Notes: motion sickness.
    Setness PA; Van Beusekom M
    Postgrad Med; 2004 Oct; 116(4):64. PubMed ID: 15510594
    [No Abstract]   [Full Text] [Related]  

  • 79. Transdermal hyoscine (Scopolamine). A preliminary review of its pharmacodynamic properties and therapeutic efficacy.
    Clissold SP; Heel RC
    Drugs; 1985 Mar; 29(3):189-207. PubMed ID: 3886352
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Content of biogenic amines and their precursors in human blood during head-down tilt and in taking pharmacological agents to prevent the motion sickness syndrome].
    Davydova NA; Il'ina SL; Sabaev VV
    Kosm Biol Aviakosm Med; 1983; 17(2):53-6. PubMed ID: 6855174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.